Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Inhibition of G-protein βγ signaling enhances T cell receptor-stimulated interleukin 2 transcription in CD4+ T helper cells.

Yost EA, Hynes TR, Hartle CM, Ott BJ, Berlot CH.

PLoS One. 2015 Jan 28;10(1):e0116575. doi: 10.1371/journal.pone.0116575. eCollection 2015.

2.

Inhibition of Gαs/cAMP Signaling Decreases TCR-Stimulated IL-2 transcription in CD4(+) T Helper Cells.

Hynes TR, Yost EA, Yost SM, Hartle CM, Ott BJ, Berlot CH.

J Mol Signal. 2015 Jul 6;10:2. doi: 10.5334/1750-2187-10-2.

3.
4.

Multicolor BiFC analysis of G protein βγ complex formation and localization.

Hynes TR, Yost EA, Yost SM, Berlot CH.

Methods Mol Biol. 2011;756:229-43. doi: 10.1007/978-1-61779-160-4_12.

5.

Multicolor BiFC analysis of competition among G protein beta and gamma subunit interactions.

Hynes TR, Yost E, Mervine S, Berlot CH.

Methods. 2008 Jul;45(3):207-13. doi: 10.1016/j.ymeth.2008.06.008. Epub 2008 Jun 27.

6.

Live cell analysis of G protein beta5 complex formation, function, and targeting.

Yost EA, Mervine SM, Sabo JL, Hynes TR, Berlot CH.

Mol Pharmacol. 2007 Oct;72(4):812-25. Epub 2007 Jun 27.

PMID:
17596375
7.
8.

Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.

McClure KF, Abramov YA, Laird ER, Barberia JT, Cai W, Carty TJ, Cortina SR, Danley DE, Dipesa AJ, Donahue KM, Dombroski MA, Elliott NC, Gabel CA, Han S, Hynes TR, Lemotte PK, Mansour MN, Marr ES, Letavic MA, Pandit J, Ripin DB, Sweeney FJ, Tan D, Tao Y.

J Med Chem. 2005 Sep 8;48(18):5728-37.

PMID:
16134941
10.

Visualization of G protein betagamma dimers using bimolecular fluorescence complementation demonstrates roles for both beta and gamma in subcellular targeting.

Hynes TR, Tang L, Mervine SM, Sabo JL, Yost EA, Devreotes PN, Berlot CH.

J Biol Chem. 2004 Jul 16;279(29):30279-86. Epub 2004 May 10.

11.

Cellular localization of GFP-tagged alpha subunits.

Hynes TR, Hughes TE, Berlot CH.

Methods Mol Biol. 2004;237:233-46. Review.

PMID:
14501054
12.

Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.

Rath VL, Ammirati M, Danley DE, Ekstrom JL, Gibbs EM, Hynes TR, Mathiowetz AM, McPherson RK, Olson TV, Treadway JL, Hoover DJ.

Chem Biol. 2000 Sep;7(9):677-82.

13.

Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.

Rath VL, Ammirati M, LeMotte PK, Fennell KF, Mansour MN, Danley DE, Hynes TR, Schulte GK, Wasilko DJ, Pandit J.

Mol Cell. 2000 Jul;6(1):139-48.

15.

Engineering alternative beta-turn types in staphylococcal nuclease.

Hynes TR, Hodel A, Fox RO.

Biochemistry. 1994 May 3;33(17):5021-30.

PMID:
8172877
16.

2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten.

Brünger AT, Leahy DJ, Hynes TR, Fox RO.

J Mol Biol. 1991 Sep 5;221(1):239-56.

PMID:
1920408
17.
18.

X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor.

Hynes TR, Randal M, Kennedy LA, Eigenbrot C, Kossiakoff AA.

Biochemistry. 1990 Oct 30;29(43):10018-22.

PMID:
2125487
19.

Transfer of a beta-turn structure to a new protein context.

Hynes TR, Kautz RA, Goodman MA, Gill JF, Fox RO.

Nature. 1989 May 4;339(6219):73-6.

PMID:
2716830
20.
21.

Movement of myosin fragments in vitro: domains involved in force production.

Hynes TR, Block SM, White BT, Spudich JA.

Cell. 1987 Mar 27;48(6):953-63.

PMID:
3548997

Supplemental Content

Loading ...
Support Center